Rezolute, Inc. RZLT
NASDAQ
Corporate Info
Website
Phone Number
650 206 4507
Address
275 Shoreline Drive
Suite 500
Redwood City, CA 94065
Suite 500
Redwood City, CA 94065
Country
United States
Year Founded
2010
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
58
Business Description
Rezolute, Inc., a late-stage rare disease company, focuses developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism (HI) in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody which is in Phase 3 clinical trial to treat tumor HI indication, as well as congenital HI. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.